Trillium Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-8,870
| Closed | -$420K | – | 237 |
|
|
2020
Q1 | $420K | Buy |
8,870
+16
| +0.2% | +$853 | 0.02% | 201 |
|
|
2019
Q4 | $520K | Sell |
8,854
-347
| -4% | -$19.3K | 0.02% | 206 |
|
|
2019
Q3 | $491K | Sell |
9,201
-14
| -0.2% | -$720 | 0.02% | 212 |
|
|
2019
Q2 | $461K | Buy |
9,215
+201
| +2% | +$10.1K | 0.02% | 199 |
|
|
2019
Q1 | $471K | Buy |
9,014
+564
| +7% | +$28.2K | 0.02% | 206 |
|
|
2018
Q4 | $403K | Sell |
8,450
-40
| -0.5% | -$1.97K | 0.02% | 204 |
|
|
2018
Q3 | $427K | Sell |
8,490
-61
| -0.7% | -$3.1K | 0.02% | 209 |
|
|
2018
Q2 | $431K | Sell |
8,551
-57
| -0.7% | -$2.87K | 0.02% | 203 |
|
|
2018
Q1 | $420K | Buy |
8,608
+1,538
| +22% | +$71.6K | 0.02% | 204 |
|
|
2017
Q4 | $314K | Sell |
7,070
-53,012
| -88% | -$2.45M | 0.02% | 206 |
|
|
2017
Q3 | $3.05M | Buy |
60,082
+2,032
| +4% | +$103K | 0.17% | 135 |
|
|
2017
Q2 | $3.13M | Buy |
58,050
+2,160
| +4% | +$115K | 0.19% | 133 |
|
|
2017
Q1 | $2.94M | Buy |
55,890
+2,256
| +4% | +$114K | 0.19% | 131 |
|
|
2016
Q4 | $2.58M | Sell |
53,634
-2,756
| -5% | -$136K | 0.17% | 133 |
|
|
2016
Q3 | $3.04M | Buy |
56,390
+48,580
| +622% | +$2.66M | 0.2% | 126 |
|
|
2016
Q2 | $423K | Sell |
7,810
-372
| -5% | -$19.6K | 0.03% | 193 |
|
|
2016
Q1 | $415K | Sell |
8,182
-255
| -3% | -$12.7K | 0.03% | 182 |
|
|
2015
Q4 | $426K | Sell |
8,437
-689
| -8% | -$35.1K | 0.03% | 187 |
|
|
2015
Q3 | $438K | Buy |
9,126
+89
| +1% | +$4.63K | 0.03% | 186 |
|
|
2015
Q2 | $471K | Sell |
9,037
-109
| -1% | -$6.14K | 0.03% | 184 |
|
|
2015
Q1 | $528K | Sell |
9,146
-868
| -9% | -$49.8K | 0.03% | 178 |
|
|
2014
Q4 | $535K | Sell |
10,014
-1,967
| -16% | -$110K | 0.04% | 176 |
|
|
2014
Q3 | $689K | Sell |
11,981
-77,248
| -87% | -$4.74M | 0.06% | 156 |
|
|
2014
Q2 | $5.96M | Buy |
89,229
+4,239
| +5% | +$287K | 0.51% | 82 |
|
|
2014
Q1 | $5.68M | Buy |
84,990
+5,584
| +7% | +$378K | 0.53% | 74 |
|
|
2013
Q4 | $5.3M | Buy |
79,406
+834
| +1% | +$54.1K | 0.52% | 87 |
|
|
2013
Q3 | $4.93M | Sell |
78,572
-58,034
| -42% | -$3.74M | 0.55% | 81 |
|
|
2013
Q2 | $8.53M | Buy |
+136,606
| New | +$8.67M | 1.05% | 34 |
|
Other funds holding GSK
